Events & Webinars

Key TakeawaysNuvisertib’s combination with other therapies could enhance treatment efficacy for MF patients Enzomenib’s targeted approach may lead to personalized treatment plans for...

Key TakeawaysZiftomenib’s high remission rates suggest it could become a frontline treatment option for AML patients with specific genetic profiles. The manageable safety...

Key TakeawaysYescarta’s consistent survival rates suggest it remains a reliable option for second-line therapy in R/R LBCL. Improvements in managing CRS and ICANS...

Key TakeawaysLivaNova's CORE-VNS study provides robust real-world evidence supporting VNS Therapy's efficacy. VNS Therapy demonstrates sustained benefits in both adult and pediatric populations...

Key TakeawaysBayer's focus on AI integration indicates a strategic move towards automating and enhancing diagnostic processes in radiology. The introduction of lower-dose contrast...

Key TakeawaysChristopher Boerner, CEO of Bristol Myers Squibb, will participate in a fireside chat at the Citi Global Healthcare Conference. The event is...

Key TakeawaysThe implementation of COT with Evolut valves significantly lowers the risk of permanent pacemaker implantation post-TAVR. Absence of moderate or severe aortic...

Key TakeawaysAsciminib demonstrates sustained efficacy and safety in long-term CML-CP treatment. Kisqali’s extended analysis highlights its effectiveness in reducing breast cancer recurrence. Novartis’s...

Key TakeawaysThe 2024 San Antonio Breast Cancer Symposium (SABCS) will host nearly 11,000 participants. Researchers, healthcare professionals, and advocates will present the latest...

Key TakeawaysLearn about fertility treatments and support at CRGH City’s Open Evening on December 4th, 2024. Meet with fertility experts Dr. Jara Ben...

Key TakeawaysPumasAI introduces DeepPumas and AskPumas, innovative AI tools for pharmacometrics and clinical pharmacology. These tools accelerate decision-making, enhance prediction accuracy, and streamline...

Key TakeawaysUnderstand the pivotal role of ethics in fostering trust between patients and healthcare providers. Explore strategies to enhance patient safety and uphold...

Key TakeawaysInvestment opportunities arise from Nyxoah's dual listing and ongoing clinical successes. Healthcare providers can expect enhanced treatment options for OSA patients with...

Key takeawaysBexotegrast shows significant potential in reducing liver fibrosis and improving biochemical markers in PSC patients. The drug's favorable safety profile across various...

Key TakeawaysBristol Myers Squibb (BMS) presented over 90 data disclosures at ASH 2024, including breakthroughs in hematology and cell therapy. The presentations underline...